Litcius/Paper detail

Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays

Arantxa Valdivia, Ignacio Torres, Víctor Latorre, Clara Francés‐Gómez, Eliseo Albert, Roberto Gozalbo‐Rovira, María Jesús Alcaráz, Javier Buesa, Jesús Rodríguez‐Díaz, Ron Geller, David Navarro

2021European Journal of Clinical Microbiology & Infectious Diseases45 citationsDOIOpen Access PDF

Topics & Concepts

VirologyTiterAntibodyImmunoassayNeutralizing antibodyImmunoglobulin GSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirusMedicineChemiluminescenceNeutralizationCoronavirus disease 2019 (COVID-19)ImmunologyChemistryInternal medicineInfectious disease (medical specialty)Organic chemistryDiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing
Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays | Litcius